$MED
MEDIFAST INC

2022 Q3 Form 10-Q Financial Statement

#000162828022020656 Filed on August 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $390.4M $453.3M $417.6M
YoY Change -5.56% 15.0% 22.58%
Cost Of Revenue $107.5M $131.7M $115.3M
YoY Change 1.14% 31.02% 25.18%
Gross Profit $282.8M $321.7M $302.3M
YoY Change -7.88% 9.52% 21.62%
Gross Profit Margin 72.45% 70.96% 72.39%
Selling, General & Admin $234.7M $272.7M $247.2M
YoY Change -6.83% 17.41% 26.28%
% of Gross Profit 82.97% 84.78% 81.78%
Research & Development $1.100M $1.200M $900.0K
YoY Change -8.33% 9.09% -10.0%
% of Gross Profit 0.39% 0.37% 0.3%
Depreciation & Amortization $2.850M $2.732M $2.444M
YoY Change 8.16% 3.48% 117.44%
% of Gross Profit 1.01% 0.85% 0.81%
Operating Expenses $234.7M $272.7M $247.2M
YoY Change -6.83% 17.41% 26.28%
Operating Profit $48.16M $48.96M $55.09M
YoY Change -12.72% -20.3% 4.33%
Interest Expense -$261.0K -$164.0K -$95.00K
YoY Change 177.66% 144.78% -513.04%
% of Operating Profit -0.54% -0.33% -0.17%
Other Income/Expense, Net -$278.0K -$168.0K -$111.0K
YoY Change -1423.81% 88.76% -364.29%
Pretax Income $47.88M $48.80M $54.98M
YoY Change -13.25% -20.46% 4.04%
Income Tax $11.72M $9.683M $13.20M
% Of Pretax Income 24.49% 19.84% 24.0%
Net Earnings $36.16M $39.11M $41.78M
YoY Change -13.88% -16.72% 1.75%
Net Earnings / Revenue 9.26% 8.63% 10.01%
Basic Earnings Per Share $3.30 $3.44 $3.62
Diluted Earnings Per Share $3.27 $3.42 $3.59
COMMON SHARES
Basic Shares Outstanding 11.02M shares 11.35M shares 11.56M shares
Diluted Shares Outstanding 11.04M shares 11.44M shares 11.64M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.4M $122.1M $240.1M
YoY Change -55.66% -68.64% -42.7%
Cash & Equivalents $69.71M $61.07M $118.0M
Short-Term Investments $69.71M $61.07M $122.1M
Other Short-Term Assets $14.45M $16.71M $13.23M
YoY Change 25.16% 50.49% 100.41%
Inventory $145.3M $157.0M $189.0M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $229.6M $243.3M $324.3M
YoY Change -23.74% -20.05% 15.04%
LONG-TERM ASSETS
Property, Plant & Equipment $58.11M $58.54M $57.80M
YoY Change 25.09% 56.64% 85.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.69M $12.96M $12.03M
YoY Change 97.1% 242.36% 286.44%
Total Long-Term Assets $96.77M $97.25M $97.18M
YoY Change 37.61% 62.32% 118.21%
TOTAL ASSETS
Total Short-Term Assets $229.6M $243.3M $324.3M
Total Long-Term Assets $96.77M $97.25M $97.18M
Total Assets $326.4M $340.6M $421.4M
YoY Change -12.12% -6.5% 29.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $148.1M $154.8M $174.4M
YoY Change -4.74% 3.87% 23.4%
Accrued Expenses $6.126M $6.378M $6.663M
YoY Change 13.4% 28.69% 80.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $27.00M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $154.3M $188.2M $181.0M
YoY Change -4.13% 22.2% 24.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $21.57M $22.91M $24.38M
YoY Change 51.71% 47.2% 269.38%
Total Long-Term Liabilities $21.57M $22.91M $24.38M
YoY Change 51.71% 47.2% 269.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $154.3M $188.2M $181.0M
Total Long-Term Liabilities $21.57M $22.91M $24.38M
Total Liabilities $175.8M $211.1M $205.4M
YoY Change 0.4% 24.49% 35.58%
SHAREHOLDERS EQUITY
Retained Earnings $131.5M $129.2M $203.1M
YoY Change -28.2% -30.29% 13.71%
Common Stock $11.00K $11.00K $12.00K
YoY Change -8.33% -8.33% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $150.5M $129.5M $216.0M
YoY Change
Total Liabilities & Shareholders Equity $326.4M $340.6M $421.4M
YoY Change -12.12% -6.5% 29.12%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $36.16M $39.11M $41.78M
YoY Change -13.88% -16.72% 1.75%
Depreciation, Depletion And Amortization $2.850M $2.732M $2.444M
YoY Change 8.16% 3.48% 117.44%
Cash From Operating Activities $55.40M $43.76M $43.67M
YoY Change 250.61% 109.35% -33.15%
INVESTING ACTIVITIES
Capital Expenditures -$1.768M -$2.840M $3.009M
YoY Change -82.98% -62.61% -34.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 $4.022M $1.245M
YoY Change 178.34% -66.35%
Cash From Investing Activities -$1.768M $1.182M -$1.764M
YoY Change -82.98% -119.22% 100.91%
FINANCING ACTIVITIES
Cash Dividend Paid $16.66M
YoY Change 24.4%
Common Stock Issuance & Retirement, Net $10.00M
YoY Change 33.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -45.11M -102.0M -$28.12M
YoY Change 5.03% 254.8% 26.56%
NET CHANGE
Cash From Operating Activities 55.40M 43.76M $43.67M
Cash From Investing Activities -1.768M 1.182M -$1.764M
Cash From Financing Activities -45.11M -102.0M -$28.12M
Net Change In Cash 8.522M -57.08M $13.82M
YoY Change -122.7% 307.63% -67.33%
FREE CASH FLOW
Cash From Operating Activities $55.40M $43.76M $43.67M
Capital Expenditures -$1.768M -$2.840M $3.009M
Free Cash Flow $57.16M $46.60M $40.66M
YoY Change 118.27% 63.52% -33.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Entity File Number
EntityFileNumber
001-31573
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Medifast, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3714405
dei Entity Address Address Line1
EntityAddressAddressLine1
100 International Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Baltimore
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21202
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
581-8042
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MED
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11017899 shares
CY2022Q2 us-gaap Revenues
Revenues
453333000 usd
CY2021Q2 us-gaap Revenues
Revenues
394189000 usd
us-gaap Revenues
Revenues
870933000 usd
us-gaap Revenues
Revenues
734858000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
131651000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
100482000 usd
us-gaap Cost Of Revenue
CostOfRevenue
246965000 usd
us-gaap Cost Of Revenue
CostOfRevenue
192604000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
321682000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
293707000 usd
us-gaap Gross Profit
GrossProfit
623968000 usd
us-gaap Gross Profit
GrossProfit
542254000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
272718000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
232273000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
519917000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
428021000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
48964000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61434000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
104051000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
114233000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-164000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-67000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-259000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-44000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-168000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-89000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-47000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48796000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
61345000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103772000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
114186000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9683000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14382000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22878000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26160000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39113000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000 usd
us-gaap Net Income Loss
NetIncomeLoss
80894000 usd
us-gaap Net Income Loss
NetIncomeLoss
88026000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.06
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.48
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.42
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.42
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11354000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11753000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11455000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11762000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11435000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11858000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11534000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11869000 shares
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.64
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.42
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.28
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.84
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39113000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000 usd
us-gaap Net Income Loss
NetIncomeLoss
80894000 usd
us-gaap Net Income Loss
NetIncomeLoss
88026000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
148000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
177000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
67000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-17000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-21000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-33000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
141000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
156000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39254000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46935000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81050000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88060000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61069000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104183000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
156974000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
180043000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
5361000 usd
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
8547000 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
945000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16710000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16334000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
243300000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
306866000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58544000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56131000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21347000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24457000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12955000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6468000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4404000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4404000 usd
CY2022Q2 us-gaap Assets
Assets
340550000 usd
CY2021Q4 us-gaap Assets
Assets
398326000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
154782000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163309000 usd
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
27000000 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6378000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6523000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
188160000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
169832000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22914000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26020000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
211074000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
195852000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11019000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11594000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11018000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11593000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12018000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
268000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
111000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
129197000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
190333000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
129476000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202474000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
340550000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398326000 usd
us-gaap Net Income Loss
NetIncomeLoss
80894000 usd
us-gaap Net Income Loss
NetIncomeLoss
88026000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5176000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2453000 usd
med Operating Lease Expense Non Cash
OperatingLeaseExpenseNonCash
3211000 usd
med Operating Lease Expense Non Cash
OperatingLeaseExpenseNonCash
2187000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5140000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4344000 usd
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
14000 usd
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
49000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23069000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42398000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
7602000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
376000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4657000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8169000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
762000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13922000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87435000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36962000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
86204000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5267000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5145000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5849000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12196000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-582000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7051000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
27000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
702000 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
1479000 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
1833000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
35617000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
30095000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100038000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19730000 usd
med Payments For Repurchase Of Common Stock Not Yet Settled
PaymentsForRepurchaseOfCommonStockNotYetSettled
20010000 usd
med Payments For Repurchase Of Common Stock Not Yet Settled
PaymentsForRepurchaseOfCommonStockNotYetSettled
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-130144000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50956000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43114000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28264000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104183000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163723000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61069000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191987000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30283000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26751000 usd
us-gaap Dividends Cash
DividendsCash
19305000 usd
us-gaap Dividends Cash
DividendsCash
17531000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202474000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
41781000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2275000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1459000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10000000 usd
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19063000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
216024000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39113000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2865000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
90038000 usd
CY2022Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
535000 shares
CY2022Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
1000 usd
CY2022Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
1000 usd
CY2022Q2 med Adjustments To Paid In Capital Share Repurchases Not Yet Settled
AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
20010000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
141000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18598000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
129476000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
157246000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
41063000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2198000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
481000 usd
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1807000 usd
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7500000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
62000 usd
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16852000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
174891000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1839000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
221000 usd
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000 usd
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12230000 usd
CY2021Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
114000 shares
CY2021Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16941000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
194689000 usd
CY2021Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
3641000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span>
CY2021Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
15991000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span>
CY2022Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
9400000 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
12942000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
15196000 usd
CY2022Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2987000 usd
CY2022Q2 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
12810000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
131435000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
152687000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3200000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
7472000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
156974000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
180043000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39113000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000 usd
us-gaap Net Income Loss
NetIncomeLoss
80894000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
7000 shares
us-gaap Net Income Loss
NetIncomeLoss
88026000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11354000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11753000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11455000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11762000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
81000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
105000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
79000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
107000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11435000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11858000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11534000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11869000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.44
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.48
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.42
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
150000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4344000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
700000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
8000 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
152000 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2865000 usd
CY2021Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
162000 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2198000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
157000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5140000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1700000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1400000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3500000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2400000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3674000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2005000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
103000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9745000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.021
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3525000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6241000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5693000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5825000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4160000 usd
CY2022Q2 med Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
5412000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
30856000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1564000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29292000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
61069000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
268000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
90000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
21000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
268000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
111000 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
61069000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
0 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61069000 usd
CY2022Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
0 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
109464000 usd
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
21000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
59000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
109544000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104183000 usd
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5361000 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-200000 usd
CY2022Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-200000 usd
CY2021Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
48964000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
480000 shares
CY2022Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
20000000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
272718000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
232273000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
61434000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9683000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14382000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39113000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
519917000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
428021000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
104051000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
114233000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22878000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26160000 usd
us-gaap Net Income Loss
NetIncomeLoss
80894000 usd
us-gaap Net Income Loss
NetIncomeLoss
88026000 usd

Files In Submission

Name View Source Status
0001628280-22-020656-index-headers.html Edgar Link pending
0001628280-22-020656-index.html Edgar Link pending
0001628280-22-020656.txt Edgar Link pending
0001628280-22-020656-xbrl.zip Edgar Link pending
ex-101medifastformpsuagree.htm Edgar Link pending
ex-102amendmentno2tomedifa.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20220331xexx3111.htm Edgar Link pending
med-20220331xexx3121.htm Edgar Link pending
med-20220331xexx3211.htm Edgar Link pending
med-20220630.htm Edgar Link pending
med-20220630.xsd Edgar Link pending
med-20220630_cal.xml Edgar Link unprocessable
med-20220630_def.xml Edgar Link unprocessable
med-20220630_htm.xml Edgar Link completed
med-20220630_lab.xml Edgar Link unprocessable
med-20220630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending